Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q3 2025
Institutional positions in Centessa Pharmaceuticals plc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 125
- +8 vs. Q2 2025
- Shares held
- 128.3M
- +4.76M (+3.9%) vs. Q2 2025
- Total value
- $3.11B
- +$1.49B (+91.7%) vs. Q2 2025
- New holders
- 26
- 31 more added
- Sold out
- 18
- 53 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 5,404 | $131.0K | 0.00% | −2,094−27.9% | Reduced |
| Barclays PLC | 4,968 | $120.5K | 0.00% | −2,551−33.9% | Reduced |
| Tower Research Capital LLC (TRC) | 3,911 | $94.8K | 0.00% | +3,432+716.5% | Added |
| Mirae Asset Global Investments Co., Ltd. | 3,709 | $89.9K | 0.00% | +20+0.5% | Added |
| GAMMA Investing LLC | 3,612 | $87.6K | 0.00% | +421+13.2% | Added |
| Rockefeller Capital Management L.P. | 3,468 | $84.1K | 0.00% | +3,468 | New |
| Simplex Trading, LLC | 2,622 | $63.0K | 0.00% | +2,622 | New |
| Group One Trading, L.P. | 2,461 | $59.7K | 0.00% | +2,461 | New |
| Wells Fargo & Company | 2,379 | $57.7K | 0.00% | +2,229+1,486.0% | Added |
| GF Fund Management Co. Ltd. | 2,064 | $50.1K | 0.00% | −219−9.6% | Reduced |
| Citigroup Inc | 1,844 | $44.7K | 0.00% | +23+1.3% | Added |
| BNP Paribas Arbitrage, SA | 1,198 | $29.1K | 0.00% | −33,774−96.6% | Reduced |
| Adirondack Trust Co | 925 | $22.4K | 0.01% | 00.0% | Unchanged |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 481 | $11.7K | 0.00% | −201−29.5% | Reduced |
| Global Retirement Partners, LLC | 350 | $8.49K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 294 | $7.00K | 0.00% | 00.0% | Unchanged |
| Aspect Partners, LLC | 230 | $5.58K | 0.00% | +230 | New |
| Washington Trust Advisors, Inc. | 184 | $4.46K | 0.00% | 00.0% | Unchanged |
| NBC Securities, Inc. | 138 | $3.35K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 81 | $1.96K | 0.00% | +81 | New |
| Bellevue Asset Management, LLC | 70 | $1.70K | 0.00% | +70 | New |
| T. Rowe Price Investment Management, Inc. | 20 | $1.00K | 0.00% | −381−95.0% | Reduced |
| SBI Securities Co., Ltd. | 21 | $509 | 0.00% | +21 | New |
| EverSource Wealth Advisors, LLC | 20 | $485 | 0.00% | 00.0% | Unchanged |
| Principal Securities, Inc. | 17 | $412 | 0.00% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −307,880−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −293,986−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −225,000−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −131,351−100.0% | Sold out |
| Bollard Group LLC | 0 | $0 | 0.00% | −100,362−100.0% | Sold out |
| Allostery Investments LP | 0 | $0 | 0.00% | −52,500−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −46,665−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −45,912−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −39,379−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −35,898−100.0% | Sold out |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −16,500−100.0% | Sold out |
| OneAscent Financial Services LLC | 0 | $0 | 0.00% | −12,324−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −11,356−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −8,999−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −1,638−100.0% | Sold out |
| National Bank of Canada | 0 | $0 | 0.00% | −1,600−100.0% | Sold out |